China Subsidy Response and Export Competitiveness Act of 2026
Sponsored By: Senator Gallego, Ruben [D-AZ]
Introduced
Summary
Expanded Ex-Im Bank authority to counter Chinese subsidies. This bill would broaden the Export-Import Bank's export-credit powers to cover domestic programs and a wider set of products and activities, aiming to neutralize subsidies and boost U.S. competitiveness relative to the People's Republic of China.
Show full summary
- U.S. manufacturers and exporters would see wider eligibility for bank support because the China and transformational exports program explicitly adds product categories like medical manufacturing and printed circuit boards. These changes refocus export-support policy to strengthen sectors the bill identifies as strategically important.
- Domestic projects and borrowers could access Ex-Im Bank guarantees after the bill inserts the phrase "or in the United States" into the statute, expanding coverage to programs conducted inside the United States. That change would let the bank back in-country activities tied to export competitiveness.
- The bill widens the bank's counter-subsidy tools by changing statutory language from "directly neutralize export subsidies" to "neutralize subsidies" and replacing "export credit" with "credit." Those wording shifts are meant to broaden the range of export-related activities the bank can support and are applied retroactively to existing statutory references where applicable.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
More export loan help for businesses
If enacted, this bill would expand what the Export-Import Bank can cover and who can qualify. It would add printed circuit boards and a new "medical manufacturing" category to covered products. It would change terms like "direct exports" to "exports" and "export credit" to "credit," widening the kinds of support that qualify. It would also allow the Bank to guarantee programs run in the United States. These changes would be effective upon enactment and do not create new funding.
Sponsors & CoSponsors
Sponsor
Gallego, Ruben [D-AZ]
AZ • D
Cosponsors
Sen. Ricketts, Pete [R-NE]
NE • R
Sponsored 6/8/2026
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov